<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have reported earlier that tight-junction proteins are detectable by standard immunohistochemistry in the brain parenchyma, namely in the cell bodies of neurons, astrocytes, and oligodendrocytes </plain></SENT>
<SENT sid="1" pm="."><plain>Here we show, by projection to latent structures - discriminate analysis (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PLS</z:e>-<z:mp ids='MP_0000273'>DA</z:mp>), that the immunohistochemical detection profile of tight junction proteins clearly distinguishes the AD cases from healthy aging controls and from the cases of <z:hpo ids='HP_0000726'>dementia</z:hpo> with a predominantly vascular pathology underlying the symptoms (vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, VaD; cerebral <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> with subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo>, CADASIL; and <z:hpo ids='HP_0011970'>cerebral amyloid angiopathy</z:hpo>, CAA) </plain></SENT>
<SENT sid="2" pm="."><plain>Our findings might be valuable in the perspective of developing biomarkers for AD </plain></SENT>
</text></document>